UCLA JCCC Event Image Female Doctors Reviewing Data
In-Person
Hosted by: Jonsson Comprehensive Cancer Center (JCCC)

"Neoadjuvant Immunotherapy Converts Hepatocellular Carcinoma (HCC) into Resectable Disease with Enhanced Antitumor Immunity" 

Speaker: Mark Yarchoan, MD,
Associate Professor
Department of Oncology
Division of Gastrointestinal Cancer
Sidney Kimmel Comprehensive Cancer Center Johns Hopkins University School of Medicine


SPONSORED BY:
UCLA Jonsson Comprehensive Cancer Center -Signal Transduction and Therapeutics (STT) Program

For any questions regarding this event please contact: jcccevents@mednet.ucla.edu